Medical Devices

FDA PMA Evidence and Submission Planning

Last reviewed: 2026-11-08

Need FDA PMA support for a higher-evidence device route? Start with intended use, clinical evidence status and manufacturing controls. Share what your team already has so a specialist can clarify PMA planning versus other US pathways.

Discuss my FDA PMA requirement

FDA PMA premarket approval evidence programme for high-risk medical devices

At a glance

Is this for you?

Manufacturers of higher-risk devices for which PMA may be the applicable pathway after specialist classification review.

What to send with your enquiry

  • Device and indication
  • Classification information
  • Design history
  • Preclinical and clinical evidence
  • Manufacturing controls
  • Risk analysis and prior FDA interactions.

What a specialist can help with

  • Initial feasibility and pathway review
  • Nonclinical/bench evidence mapping
  • Clinical-evidence workstream coordination where applicable
  • Manufacturing and QMS readiness planning
  • Submission-project coordination
  • Response/workstream tracking
Scope and report acceptance. PMA evidence planning requires verified senior regulatory and clinical capability. FDA alone decides an application.
Role clarity. Enquiry support and specialist introductions. Testing, technical advice, certification and regulatory decisions remain with the responsible service providers and authorities.

Premarket approval (PMA) is a demanding FDA pathway for applicable devices. It is not interchangeable with 510(k) clearance or De Novo classification. ConformArc can coordinate a specialist feasibility and evidence review when the product’s classification and development stage warrant it.

The first work package should confirm the regulatory route and map nonclinical, clinical, manufacturing, quality-system and labelling evidence against current FDA expectations. Significant gaps may require a multi-stage programme and discussions with FDA through appropriate channels. The deliverable is a scoped development and submission plan with owners, dependencies and uncertainties, not a promise of approval. FDA alone decides an application.

Frequently asked questions

Is PMA a faster form of 510(k)?

No; the standards and evidence burden differ.

Sources / further reading

Requirements can change. Confirm the current route and applicable edition for the specific product before starting the project.

Discuss this requirement

Tell us the product or company requirement, target market, current stage and what your customer has asked for. We will review the initial details and reply about the next step. You can start without uploading confidential documents.

We use your details to respond to this enquiry. If a suitable external specialist could help, we will tell you who we propose to contact and ask before sharing your name, contact details or project information. The specialist may then contact you about this request. Read the Privacy Notice. See also how we choose providers.

Related options for FDA PMA.

Add more details (optional)

We use your details to respond to this enquiry. If a suitable external specialist could help, we will tell you who we propose to contact and ask before sharing your name, contact details or project information. Please do not include passwords, confidential documents or sensitive personal information.